We are live on ! Find out more
RNTX

Rein Therapeutics
RNTX

36 hedge funds and large institutions have $9.54M invested in Rein Therapeutics in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 5

2.28% more ownership

Funds ownership: 27.77% → 30.05% (+2.3%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

8% less funds holding

Funds holding: 39 → 36 (-3)

10% less capital invested

Capital invested by funds: $10.6M → $9.54M (-$1.1M)

38% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 8

Holders
36
Holders Change
-3
Holders Change %
-7.69%
% of All Funds
0.47%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
5
Increased
9
Reduced
5
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VC
Voss Capital
Texas
+$798K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$301K
3
Citadel Advisors
Citadel Advisors
Florida
+$86.4K
4
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$59.8K
5
GG
Gleason Group
Kentucky
+$40.3K

Top Sellers

Rank Fund Capital Flow
1
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$101K
2
SPC
Sigma Planning Corp
Michigan
-$51.1K
3
TSS
Two Sigma Securities
New York
-$28.8K
4
NFSG
Newbridge Financial Services Group
Florida
-$19.8K
5
Morgan Stanley
Morgan Stanley
New York
-$7.61K
Name Holding Trade Value Shares
Change 		Change in
Stake
Cetera Investment Advisers
26
Cetera Investment Advisers
Illinois
$19.1K +$24.6K +13,646 New
GRP
27
Global Retirement Partners
California
$10.1K +$13K +7,200 New
TRCT
28
Tower Research Capital (TRC)
New York
$4.1K -$947 -526 -15%
Wells Fargo
29
Wells Fargo
California
$2.36K +$3.04K +1,686 +84,300%
JWA
30
JFS Wealth Advisors
Pennsylvania
$2.23K – – –
US Bancorp
31
US Bancorp
Minnesota
$1.75K – – –
Bank of America
32
Bank of America
North Carolina
$367 +$38 +21 +9%
Osaic Holdings
33
Osaic Holdings
Arizona
$49 -$189 -105 -75%
BTI
34
Blue Trust Inc
Georgia
$28 – – –
Citigroup
35
Citigroup
New York
$1 +$2 +1 New
Royal Bank of Canada
36
Royal Bank of Canada
Ontario, Canada
– -$101K -57,257 Closed
TSS
37
Two Sigma Securities
New York
– -$28.8K -16,271 Closed
NFSG
38
Newbridge Financial Services Group
Florida
– -$19.8K -11,194 Closed
Morgan Stanley
39
Morgan Stanley
New York
– -$7.61K -4,300 Closed
HCP
40
Hexagon Capital Partners
Arkansas
– -$377 -213 Closed
JP Morgan Chase
41
JP Morgan Chase
New York
– -$57 -32 Closed
GPFA
42
Game Plan Financial Advisors
Ohio
– -$44 -25 Closed
1
2

RNTX Hedge Fund Activity: Q2 2025 in Review

36 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Rein Therapeutics (RNTX) for Q2 2025, worth a combined $9.54M — down 10% from $10.6M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of RNTX and 5 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 9 added.

The largest buyer was Voss Capital, adding an estimated $798K. The largest seller was Royal Bank of Canada, exiting entirely with an estimated $101K sold.

  • 36 institutional investors held Rein Therapeutics (RNTX) as of Q2 2025, down from 39 in Q1 2025.
  • Funds reported $9.54M of Rein Therapeutics stock for Q2 2025, down 10% quarter-over-quarter.
  • 5 funds opened new Rein Therapeutics positions in Q2 2025 and 8 closed out, a net change of -3 holders.
  • The largest Rein Therapeutics buyer in Q2 2025 was Voss Capital, an estimated $798K added.
  • The largest Rein Therapeutics seller in Q2 2025 was Royal Bank of Canada, an estimated $101K sold.

Based on aggregated 13F filings for Q2 2025.